Company Profile
Ningbo Aucheer Biotechnology Co., Ltd. is a China-based manufacturer of in-vitro diagnostic (IVD) reagents and instruments, headquartered in Ningbo, Zhejiang, China. Founded in 2009, the company operates as an independent entity, serving maternal-fetal health, cardiovascular, infectious disease, and genetic diagnostics in over 20 provinces across China.
Core Products & Technologies
Preeclampsia Screening & Maternal-Fetal Health
• PlGF Detection Kit (Immunofluorescence / CLIA): Quantitative assay for placental growth factor, aiding early preeclampsia risk prediction
• PlGF/sFlt-1 Combined Detection Kit: Dual-marker panel for comprehensive preeclampsia screening and monitoring
• sFlt-1 CLIA Kit: Chemiluminescence assay for soluble fms-like tyrosine kinase-1 in serum
• PAPP-A CLIA Kit: Pregnancy-associated plasma protein A quantitative detection for Down syndrome risk assessment
• AFP, uE3, Free beta-hCG CLIA Kits: Second-trimester serum screening markers for fetal chromosomal anomaly risk
Diagnostic Instruments & Platforms
• iRaTe 300 / iRaTe 1600 Dry Fluorescence Immunoassay Analyzer: POCT platform for rapid quantitative detection of immunofluorescence assays
• Shine i1910 Chemiluminescence Analyzer: Medium-throughput automated CLIA system for medium or small labs
• iMAGIN 1800 Chemiluminescence Analyzer: High-throughput system designed for large-scale central lab testing
• iSort 300 / iSort 2000 Microfluidic Fluorescence Immunoassay Platform: Chip-based system enabling whole-blood sample processing without external drive
• MQ-D200 / MQ-i200 / MQ-L200 Digital PCR System: Molecular diagnostic platform for genetic disease and infectious disease testing
Additional Reagent Portfolio
• AMH Test Kit: Anti-Mullerian hormone quantitative detection for ovarian reserve assessment
• FA CLIA Kit: Folic acid quantitative detection for prenatal nutrition monitoring
• NT-proBNP / hs-cTnT / CK-MB / MYO / D-Dimer / HCY Kits: Cardiac biomarker assays for cardiovascular risk evaluation
• PCT / IL-6 Kits: Infection and inflammation biomarker detection
• 25-OH-Vit-D / 25-OH-Vit-D3 / VB12 / Fer Kits: Bone metabolism and anemia detection reagents
• Pepsinogen I / II, Gastrin-17 Kits: Gastrointestinal health assessment on CLIA platform
Market Position & Certifications
Aucheer Biotechnology holds a leading position in the domestic Chinese maternal-fetal health IVD market, competing with major POCT and chemiluminescence manufacturers. Key strengths include:
• 15+ years of Chinese IVD engineering heritage
• Microfluidic chip technology: Time-resolved fluorescence immunodetection with 12-month precision flow control
• Regulatory compliance: NMPA registered (50+ reagents and instruments), CE marked, ISO 13485 certified
• Provincial postdoctoral research workstation and microfluidic engineering center accreditation
• Zhejiang Province "New and Excellent Medical Device" List (2024): PlGF and sFlt-1 test kits selected
• Global service network: Localized technical support and OEM/ODM/CDMO services available
Corporate Timeline
2009 - Founded in Ningbo, focusing on early disease detection, diagnosis, prevention and monitoring
2014 - Established immunodiagnostic detection technology platform, laying foundation for PlGF development
2017 - Named "Ningbo Most Investment-Worthy Enterprise" and "Zhejiang High-Growth Technology Enterprise"
2019 - Approved to establish provincial postdoctoral research workstation; PlGF detection kit received NMPA approval
2023 - Launched digital PCR platform (MQ series), expanding into genetic disease diagnostics (SMA, SCID, hereditary deafness)
2024 - Won First Prize of Chongqing Science and Technology Progress Award for preeclampsia diagnosis innovation; PlGF and sFlt-1 kits listed in Zhejiang "New and Excellent Medical Device" catalog
Target Markets & Applications
• Obstetrics & Gynecology: Preeclampsia screening, ovarian function assessment (AMH), folate monitoring, anemia detection
• Perinatal Care: Down syndrome risk assessment (PAPP-A, AFP, uE3, free beta-hCG), prenatal nutrition analysis
• Cardiology: NT-proBNP, hs-cTnT, CK-MB, MYO, D-Dimer and homocysteine detection for cardiovascular risk evaluation
• Infectious Disease & Inflammation: PCT and IL-6 quantitative detection for sepsis and acute infection monitoring
• Genetic Diagnostics: SMA, SCID, hereditary deafness, DMD screening via digital PCR platform
• Clinical Laboratories: Chemiluminescence, POCT, microfluidic and molecular diagnostic solutions for medium to large-scale workflows
Contact Information
Global Headquarters
Address: No. 885 Chunhua Road, Wangchun Industrial Park, Haishu District, Ningbo, Zhejiang 315000, China
Tel: +86 574 87732259 / 400-008-6588
Email: hr@aucheer.net
Website: aucheer.net (CLOSED)
Investor Relations
Aucheer Biotechnology operates as an independent private entity with no publicly traded stock. For partnership and OEM/CDMO inquiries, contact the headquarters directly.
